Veon (VEON) Asset Writedowns and Impairment (2011 - 2026)

Veon has reported Asset Writedowns and Impairment for 16 years, with the latest figure at $2.0 million in Q2 2026.

• Asset Writedowns and Impairment for Q2 2026 came in at $2.0 million, up 100.0% year-over-year; the trailing twelve-month figure through Jun 2026 was -$5.0 million (down 183.33% YoY), and the FY2025 annual result was $9.0 million, up 200.0% from the prior year.
• Asset Writedowns and Impairment climbed to $2.0 million in Q2 2026, from $1.0 million in the prior quarter.
• Over five years, Asset Writedowns and Impairment peaked at $13.0 million in Q2 2022 and troughed at -$7.0 million in Q2 2023.
• A 5-year average of $1.6 million and a median of $1.0 million in 2025 frame the typical range for Asset Writedowns and Impairment.
• The widest annual swing landed in 2022, when Asset Writedowns and Impairment jumped 533.33%; it then slumped 153.85% in 2023.
• A 5-year view of Asset Writedowns and Impairment shows it stood at $13.0 million in 2022, then plunged by 153.85% to -$7.0 million in 2023, then jumped by 85.71% to -$1.0 million in 2024, then surged by 200.0% to $1.0 million in 2025, then surged by 100.0% to $2.0 million in 2026.
• Per Business Quant data, the three most recent Asset Writedowns and Impairment figures were $2.0 million in Q2 2026, $1.0 million in Q2 2025, and -$1.0 million in Q2 2024.